Geode Capital Management, LLC Isoray, Inc. Transaction History

Geode Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	N/A	1,859,028 Added 73.87%	4,375,677 $3.02 Million
Q3 2023 Nov 13, 2023	BUY	N/A	66,750 Added 2.72%	2,516,649 $1.74 Million
Q2 2023 Aug 11, 2023	BUY	$0.0 - $0.69 $0 - $404,162	585,743 Added 31.42%	2,449,899 $1.69 Million
Q1 2023 May 15, 2023	BUY	$0.0 - $0.67 $0 - $484,142	722,601 Added 63.3%	1,864,156 $1.19 Million
Q4 2022 Feb 13, 2023	BUY	$0.24 - $0.4 $2,508 - $4,180	10,450 Added 0.92%	1,141,555 $282,000
Q2 2022 Aug 12, 2022	BUY	$0.26 - $0.37 $3,129 - $4,452	12,035 Added 1.08%	1,131,105 $349,000
Q2 2021 Aug 13, 2021	BUY	$0.75 - $1.15 $101,132 - $155,069	134,843 Added 13.7%	1,119,070 $892,000
Q1 2021 May 12, 2021	BUY	$0.53 - $2.47 $350,060 - $1.63 Million	660,491 Added 204.02%	984,227 $1.07 Million
Q1 2020 May 14, 2020	BUY	$0.53 - $0.99 $27,065 - $50,556	51,067 Added 18.73%	323,736 $171,000
Q4 2019 Feb 13, 2020	BUY	$0.3 - $0.69 $867 - $1,994	2,891 Added 1.07%	272,669 $170,000
Q2 2017 Aug 14, 2017	BUY	N/A	269,778	269,778 $168,000

287K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.